Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A

Authors: Reckamp, Karen L., Redman, Mary W., Dragnev, Konstantin H., Minichiello, Katherine, Villaruz, Liza C., Faller, Bryan, Al Baghdadi, Tareq, Hines, Susan, Everhart, Leah, Highleyman, Louise, Papadimitrakopoulou, Vassiliki, Gandara, David R., Kelly, Karen, Herbst, Roy S.

Source: Journal of clinical oncology. 40(21):2295-2306

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100167477114.0x000001&indx=1&recIds=ETOCvdc_100167477114.0x000001

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

Authors: Redman, Mary W ^*, Papadimitrakopoulou, Vassiliki A, Minichiello, Katherine, Hirsch, Fred R, Mack, Philip C, Schwartz, Lawrence H, Vokes, Everett, Ramalingam, Suresh, Leighl, Natasha, Bradley, Jeff, Miao, Jieling, Moon, James, Highleyman, Louise, Miwa, Crystal, LeBlanc, Michael L, Malik, Shakun, Miller, Vincent A, Sigal, Ellen V, Adam, Stacey, Wholley, David, Sigman, Caroline, Smolich, Beverly, Blanke, Charles D, Kelly, Karen, Gandara, David R, Herbst, Roy S

Source: In The Lancet Oncology December 2020 21(12):1589-1601

A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol.

Authors: Neal, Joel W, Minichiello, Katherine, Brennick, Ryan, Huang, Richard S P, Hiemenz, Matthew C, Amler, Cornel, Patel, Jyoti, Herbst, Roy, Reckamp, Karen L, Borghaei, Hossein, Highleyman, Louise, Redman, Mary W, Pasquina, Lincoln W, Kozono, David E

Source: Oncologist; Jun2024, Vol. 29 Issue 6, pe843-e847, 5p

Subject Terms: GENOMICS, DNA, TUMOR markers, LUNGS, DESCRIPTIVE statistics, BIOINFORMATICS, SEQUENCE analysis

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.

Authors: Gettinger, Scott N., Redman, Mary W., Bazhenova, Lyudmila, Hirsch, Fred R., Mack, Philip C., Schwartz, Lawrence H., Bradley, Jeffrey D., Stinchcombe, Thomas E., Leighl, Natasha B., Ramalingam, Suresh S., Tavernier, Susan S., Yu, Hui, Unger, Joseph M., Minichiello, Katherine, Highleyman, Louise, Papadimitrakopoulou, Vassiliki A., Kelly, Karen, Gandara, David R., Herbst, Roy S.

Source: JAMA Oncology; Sep2021, Vol. 7 Issue 9, p1368-1377, 10p